Company Vaxxinity, Inc.

Equities

VAXX

US92244V1044

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 03:59:47 2024-05-17 pm EDT			5-day change	1st Jan Change
0.081 ^USD	+45.95%		+58.82%	-90.47%

May. 13	Vaxxinity, Inc.(OTCPK:VAXX) dropped from S&P Global BMI Index	CI
May. 13	Vaxxinity, Inc.(OTCPK:VAXX) dropped from S&P TMI Index	CI

Vaxxinity, Inc. is a biotechnology company. The Company is engaged in the development of rationally designed prophylactic and therapeutic vaccines to combat common chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its synthetic peptide-based Active Immunotherapy Medicines Platform (AIM Platform, formerly called the Vaxxine Platform) has the potential to enable a new class of medicines. Its pipeline consists of five lead programs focused on chronic disease, particularly neurodegenerative disorders, in addition to other neurology and cardiovascular indications. Its pipeline includes UB-311, UB-312, VXX-301, VXX-401 and UB-313. It also has developed an infectious disease product candidate, UB-612, as a heterologous booster against COVID-19. Its UB-311, which targets the primary pathological process of Alzheimerâs disease (AD) and UB-312, which targets the pathological process of Parkinsonâs disease (PD) and other so-called synucleinopathies.

Number of employees: 61

Managers	Title	Age	Since
Mei Mei Hu FOU	Founder	41	13-12-31
Jason Pesile DFI	Director of Finance/CFO	50	22-01-02
Sumita Ray ADM	Chief Administrative Officer	50	23-09-30
Mark Joinnides IRC	Investor Relations Contact	-	20-02-29
Jon Harrison LAW	General Counsel	-	-
Amy B. Fix LAW	General Counsel	-	-
Thomas P. Monath PRN	Corporate Officer/Principal	83	-

Members of the board	Title	Age	Since
Gabrielle Toledano BRD	Director/Board Member	57	23-01-31
Peter Diamandis BRD	Director/Board Member	62	21-02-01
George Hornig BRD	Director/Board Member	69	22-01-02
Louis Reese FOU	Founder	42	13-12-31
James Smith BRD	Director/Board Member	43	23-01-31
Mei Mei Hu FOU	Founder	41	13-12-31
Landon Ogilvie BRD	Director/Board Member	46	23-01-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	10	13,874,132	0	0	43.67 %
Stock B	1	112,910,552	55,361,530 ( 49.03 %)	0

Name	Equities	%	Valuation
Mei Mei Hu 57.67 %	65,096,861	57.67 %	8 M $
Adage Capital Partners GP LLC 2.658 %	3,000,000	2.658 %	363 000 $
BlackRock Advisors LLC 2.223 %	2,509,133	2.223 %	303 605 $
Vanguard Fiduciary Trust Co. 2.137 %	2,411,679	2.137 %	291 813 $
Peter Diamandis 0.8150 %	919,965	0.8150 %	111 316 $
Geode Capital Management LLC 0.7783 %	878,543	0.7783 %	106 304 $
STATE STREET CORPORATION 0.7081 %	799,273	0.7081 %	96 712 $
Northern Trust Investments, Inc.(Investment Management) 0.2806 %	316,713	0.2806 %	38 322 $
Creative Planning LLC 0.2541 %	286,862	0.2541 %	34 710 $
Bridgeway Capital Management LLC 0.2030 %	229,100	0.2030 %	27 721 $

Name	Equities	%	Valuation
Mei Mei Hu 39.78 %	5,518,961	39.78 %	667 794 $
Louis Reese 28.51 %	3,955,512	28.51 %	478 617 $
Peter Diamandis 7.928 %	1,099,915	7.928 %	133 090 $

Vaxxinity, Inc.

505 Odyssey Way

32953, Exploration Park

http://www.vaxxinity.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
VAXXINITY, INC.	-90.47%	7.03M
MODERNA, INC.	+33.63%	50.85B
IQVIA HOLDINGS INC.	-0.09%	42.82B
LONZA GROUP AG	+49.62%	42.03B
CELLTRION, INC.	-4.96%	29.55B
ICON PUBLIC LIMITED COMPANY	+11.18%	26.11B
ALNYLAM PHARMACEUTICALS, INC.	-21.95%	19.13B
BIO-TECHNE CORPORATION	+8.61%	13.05B
MEDPACE HOLDINGS, INC.	+28.31%	12.16B
UNITED THERAPEUTICS CORPORATION	+24.73%	12.08B

Other Biotechnology & Medical Research